[Agria Streamlines Operations Management Beijing, China September 3, 2010 Since disposing of P3A in July 2010, Agrias business operations in China are focused on creating a profitable seed business. This business comprises three business units: research and development, production and marketing. Agria has recruited managers with many years of experience in both domestic and international seed companies to lead]
[Agria Streamlines Operations Management Beijing, China September 3, 2010 Since disposing of P3A in July 2010, Agrias business operations in China are focused on creating a profitable seed business. This business comprises three business units: research and development, production and marketing. Agria has recruited managers with many years of experience in both domestic and international seed companies to lead]
[Agria Streamlines Operations Management Beijing, China September3, 2010 Since disposing of P3A in July2010,rias business operations in China are focused on creating a profitable seed business. This businessmprises three business units: research and development, production and marketing.ria has recruited managers with many years of experience in both domestic and international seedmpanies to lead each of]
[Agria Streamlines Operations Management Beijing, China September3, 2010 Since disposing of P3A in July2010,rias business operations in China are focused on creating a profitable seed business. This businessmprises three business units: research and development, production and marketing.ria has recruited managers with many years of experience in both domestic and international seedmpanies to lead each of]
[Agria Streamlines Operations Management Beijing, China September3, 2010 Since disposing of P3A in July2010,rias business operations in China are focused on creating a profitable seed business. This businessmprises three business units: research and development, production and marketing.ria has recruited managers with many years of experience in both domestic and international seedmpanies to lead each of]
[Agria Streamlines Operations Management Beijing, China September3, 2010 Since disposing of P3A in July2010,rias business operations in China are focused on creating a profitable seed business. This businessmprises three business units: research and development, production and marketing.ria has recruited managers with many years of experience in both domestic and international seedmpanies to lead each of]
[SKYSTAR ANNOUNCES UPDATE XI'AN, CHINA – September 7, 2010 - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Acquisition in Hubei Province The Company completed acquisition of a modern, GMP-certified veterinary medicine facility in Hubei Province on August 11, 2010. Skystar estimates the Hubei facility, located in Jingzhou, Hubei Province, will contribute about $4 million to $6 million in revenue]
[SKYSTAR ANNOUNCES UPDATE XI'AN, CHINA – September 7, 2010 - Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) ("Skystar" or the "Company"), Acquisition in Hubei Province The Company completed acquisition of a modern, GMP-certified veterinary medicine facility in Hubei Province on August 11, 2010. Skystar estimates the Hubei facility, located in Jingzhou, Hubei Province, will contribute about $4 million to $6 million in revenue]
[Agria Streamlines Operations Management Beijing, China September3, 2010 Since disposing of P3A in July2010, Agrias business operations in China are focused on creating a profitable seed business. This business comprises three business units: research and development, production and marketing. Agria has recruited managers with many years of experience in both domestic and international seed companies]
[Biostar Pharmaceuticals, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 12:30 pm ET XIANYANG, China, Sep. 7 - Biostar Pharmaceuticals, Inc. (Nasdaq:BSPM) ("Biostar" or "the Company"), Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsules ("Xin Aoxing Capsules"), and a variety of pharmaceutical products, today announced that]
